Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.108 EUR | -0.92% | +8.22% | -34.55% |
Sep. 28 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Jun. 06 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Sales 2021 | 4.06M 4.39M | Sales 2022 | 1.44M 1.56M | Capitalization | 15.64M 16.88M |
---|---|---|---|---|---|
Net income 2021 | -5M -5.4M | Net income 2022 | -19M -20.52M | EV / Sales 2021 | 7.53 x |
Net cash position 2021 | 7.95M 8.59M | Net cash position 2022 | 4.45M 4.81M | EV / Sales 2022 | 7.75 x |
P/E ratio 2021 |
-6
x | P/E ratio 2022 |
-0.76
x | Employees | 39 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 73.93% |
1 day | -0.92% | ||
1 week | +8.22% | ||
Current month | -7.69% | ||
1 month | -13.25% | ||
3 months | -33.33% | ||
6 months | -56.80% | ||
Current year | -34.55% |
Managers | Title | Age | Since |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 21-05-31 |
Ashish Gulati
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Miara
BRD | Director/Board Member | - | 20-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 21-10-13 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 60 | 11-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.108 | -0.92% | 47 875 |
24-03-27 | 0.109 | +11.00% | 126,513 |
24-03-26 | 0.0982 | -0.20% | 62,178 |
24-03-25 | 0.0984 | -2.09% | 62,308 |
24-03-22 | 0.1005 | +0.70% | 22,287 |
Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.55% | 18.17M | |
+34.85% | 701B | |
+26.24% | 571B | |
+1.11% | 381B | |
+20.86% | 334B | |
+17.06% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-2.59% | 157B |